Behrens M Kathleen's Form 4 filing
IGM Biosciences, Inc. (IGMS) · filed Apr 4, 2022
- Accession no.
- 0001209191-22-022716
- Filed
- Apr 4, 2022
- Trade date
- Mar 31-Apr 1, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $1.40M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Behrens M KathleenCIK 0001211701 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Common Stock | AGrant or awardAcquired | +374 | $0.00 | $0 | 2,646 | Direct | |
| Apr 1, 2022 | Common Stock | PPurchaseAcquired | +43,478 | $23.00 | +$999,994 | 158,200 | Indirect | |
| Apr 1, 2022 | Common Stock | PPurchaseAcquired | +8,696 | $23.00 | +$200,008 | 29,807 | Indirect | |
| Apr 1, 2022 | Common Stock | PPurchaseAcquired | +8,695 | $23.00 | +$199,985 | 29,806 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.